Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Target

systemic anticancer therapy

2 abstracts

Abstract
Characterizing the authorship of phase 3 randomized clinical trials in oncology, 1960-2023.
Org: Brown University/Legorreta Cancer Center, Dana-Farber Cancer Institute, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, University of Kansas Medical Center,
Abstract
Real-world (RW) treatment and surveillance patterns in patients with hepatocellular carcinoma (HCC) after resection (R) or ablation (A): Evidence from commercial and Medicare populations.
Org: Genentech,